SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Referencias del artículo

SANTANA, Alfredo et al. Biología celular y molecular del virus de inmunodeficiencia humana (VIH). Rev Diagn Biol [online]. 2003, vol.52, n.1, pp.07-18. ISSN 0034-7973.

    1. Barre-Sinoussi F, Cherman J, Rey F et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immnune deficiency syndrome (AIDS). Science 1983; 220:868. [ Links ]

    2. Gallo R, Salahuddin S, Popovic M et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984; 224:500. [ Links ]

    3. Leis J. Standardized and simplified nomenclature for proteins common to all retroviruses. J Virol 1988; 62:1808. [ Links ]

    4. Gelderblom H. Fine structure of VIH and SIV. En: Korber B, eds. VIH Molecular Immunology Database 1997. National Institute of Allergy and Infectious Diseases; 1997. [ Links ]

    5. Muesing M, Smith D, Cabradilla C et al. Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus. Nature 1985; 313:450-58. [ Links ]

    6. Cullen B. Human immunodeficiency virus as a prototypic complex retrovirus. J Virol 1991; 65:1053. [ Links ]

    7. Myers G, Pavlakis G. Evolutionary potential of complex retroviruses. En: Levy J, eds. The Retroviridae. p1 New York, Plenum Press; 1992. [ Links ]

    8. Dalgleish A, Beverly P, Clapham P et al. The CD4(T4) antigen is an essential component of the receptor for the AIDS virus. Nature (London) 1984; 312:763. [ Links ]

    9. McDouglas J, Mawle A, Cort S et al. Cellular tropism of the human retrovirus HTLV-III/LAV. Role of T cell activation and expression of the T4 antigen. J Immunol 1985; 135:3151. [ Links ]

    10. Maddon P, Dalgleish, McDougal J et al. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 1986; 47:333. [ Links ]

    11. McDouglas J, Nicholson J, Cross G et al. Binding of the human retrovirus HTLV-III/LAV/ARV/VIH to the CD4 (T4) molecule; conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry. J Immunol 1986; 137:2937. [ Links ]

    12. Sattentau Q, Clapham P, Weiss R et al. The human and simian immunodeficiency viruses VIH-1, VIH-2 and SIV interact with similar epitopes an their cellular receptor, the CD4 molecule. AIDS 1988; 2:101. [ Links ]

    13. Harouse J, Bhat S, Spitalnik S et al. Inhibition of entry of VIH-1 in neural cell lines by antibodies against galactosyl ceramide. Science 1991; 253:320. [ Links ]

    14. Kowalski M, Potz J, Basiripour L et al. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science 1987; 237:1351. [ Links ]

    15. Lasky L, Nakamura G, Smith D et al. Delineation of a region of the human immunodeficiency virus type1. gp120 glycoprotein critical for interaction with the CD4 receptor. Cell 1987; 50:975. [ Links ]

    16. Stein B, Gowda S Lifson et al. PH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma mambrane. Cell 1987; 49:659. [ Links ]

    17. McClure M, Marsh M, Weiss R. Human immunodeficiency virus infection of CD4-bearing cells occurs by a pH-independent mechanism. EMBO J 1988; 7:513. [ Links ]

    18. McClure M, Sommerfelt M, Marsh M et al. The pH independence of mammalian retrovirus infection. J Gen Virol 1990; 71:767. [ Links ]

    19. Gallaher W. Detection of a fusion peptide sequence in the transmembrane protein of VIH. Cell 1987; 50:327. [ Links ]

    20. Freed E, Myers D, Risser R. Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. Proc Natl Acad Sci USA 1990; 87:4650. [ Links ]

    21. White J. Viral and cellular membrane fusion proteins. Annu Rev Physiol 1990; 52:675. [ Links ]

    22. Alkhatib G, Combadiere C, Broder C et al. CC CKR5: A RANTES, Mip-1a, Mip-1b receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996; 272:1955. [ Links ]

    23. Deng H, Liu R, Ellmeier W et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996; 381:661. [ Links ]

    24. Dragic T, Litwin V, Allaway G et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996; 381:667. [ Links ]

    25. Choe H, Farzan M, Sun Y et al. The chemokine receptors CCR3 y CCR5 facilitate unfection by primary HIV-1 isolates. Cell 1996; 85:1135. [ Links ]

    26. Doranz B, Rucker J, Yi Y et al. A dual tropic primary HIV-1 isolate that uses fusin andchemokine receptors CKR-5, CKR-3 and CKR-2b as fusion cofactors. Cell 1996; 85:1149. [ Links ]

    27. Lori F, di Marzo Veronese F, De vico A. Viral ADN carried by human immunodeficiency virus type 1 virions. J Virol 1992; 66:5067. [ Links ]

    28. Trono D. Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses. J Virol 1992; 66:4893. [ Links ]

    29. Bukrinsky M, Sharova N, McDonald T et al. Association of integrase, matrix, and reverse trancriptase antigens of human immunodeficiency virus type 1 with viral nucleic acida following acute infction. Proc Natl Acad Sci USA 1993; 90:6125. [ Links ]

    30. Varmus H, Swanstrom R. Replication of retroviruses. En: Weiss RA, Teich N, Varmus H, Coffin J (eds); ARN Tumour Viruses, p75. Cold Spring Harbor, New York, Cold Spring Harbor Laboratory, 1985; Varmus H. Retroviruses. Science 1988; 240:1427. [ Links ]

    31. Liu H, Wu X, Newman M et al. The vif protein of human and simian immunodeficiency viruses is packaged into virions ans associates with viral core structures. J Virol 1995; 69:7630. [ Links ]

    32. Karczewski M, Strebel K. Cytoskeletal association and virion incorporation of the human immunodeficiency virus type 1 Vif protein. J Virol 1993; 67:4945. [ Links ]

    33. Bukrinsky M, Sharova N, Dempsey M et al. Active nuclear import of human immunodeficiency virus type 1 ipreintegration complexes. Proc Natl Acad Sci USA 1992; 89:6580. [ Links ]

    34. Bukrinsky M, Haggerty S, Dempsey M et al. Nuclear localization signal within VIH-1 matrix protein that governs infection of non-dividing cells. Nature 1993; 365:666. [ Links ]

    35. Heinzinger N, Bukrinsky M, Haggerty S et al. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc Natl Acad Sci USA 1994; 91:7311. [ Links ]

    36. Von Schwedler U, Kornbluth R, Trono D et al. The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes. Proc Natl Acad Sci USA 1994; 91:7311. [ Links ]

    37. Gallay P, Swingler S, Aiken C et al. VIH-1 infection of nondividing cells; C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell 1995; 80:379. [ Links ]

    38. Pemberton L, Blobel G, Rosenblum J. Transport routes through the nuclear pore complex. Curr Opin Cell Biol 1998; 10:392. [ Links ]

    39. Gallay P, Stitt V, Mundy C et al. Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import. J Virol 1996; 70:1027. [ Links ]

    40. Gallay P, Hope T, Chin D et al. HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc Natl Acad Sci USA 1997; 94:9825. [ Links ]

    41. Bukrinsky M, Haffar O. HIV-1 nuclear import: in search of a leader. Front Biosci 1997; 2:d578. [ Links ]

    42. Shih C, Stoye J, Coffin J. Highly preferred targets for retrovirus integration. Cell 1988; 53:531. [ Links ]

    43. Pryciak P, Varmus H. Nuclesomes, DNA binding proteins, and DNA sequence modulate retroviral target site selection. Cell 1992; 69:769. [ Links ]

    44. Brown P, Bowerman B, Varmus H et al. Correct integration of retroviral DNA in vitro. Cell 1987; 49:347. [ Links ]

    45. Fujiwara T, Mizuuchi K. Retroviral DNA integration: Structure of an integration intermediate. Cell 1988; 54:497. [ Links ]

    46. Brown P, Bowerman B, Varmus H et al. Retroviral integration: Structure of the initial covalent product and its precursor, and a role for the viral IN protein. Proc Natl Acad Sci USA 1989; 86:2525. [ Links ]

    47. Goff S. Genetics of retroviral integration. Annu Rev Genetics 1992; 26:527. [ Links ]

    48. Engelman A, Mizuuchi K, Craigie R. HIV-1 DNA integration: Mechanism of viral DNA cleavage and DNA strand transfer. Cell 1991; 67:1211. [ Links ]

    49. Chowers M, Spina C, Kwoh T et al. Optimal infectivity in vitro of human immunodeficiency virus type 1 requieres an intact nef gene. J Virol 1994; 68:2906. [ Links ]

    50. Miller M, Warmerdam M, Gaston I et al. The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J Exp Med 1994; 179:101. [ Links ]

    51. Chowers M, Pandori M, Spina C et al. The growth advantage conferred by HIV-1 nef is determined at the level of viral DNA formation and is independent of CD4 downregulation. Virology 1995; 212:451. [ Links ]

    52. Neumann M, Kleinschmidt A, Felber B et al. Restriction of VIH-1 production in a human astrocytoma cell line is associated with a cellular block in Rev function. J Virol 1994; 69:2159. [ Links ]

    53. Tornatore C, Meyers K, Atwood W et al. Temporal patterns of human immunodeficiency virus type 1 transcripts in human fetal astrocytes. J Virol 1994; 68:93. [ Links ]

    54. Saksela K, Stevens C, Rubinstein P et al. Human immunodeficiency virus type 1 mARN expression in peripheral blood cells predicts disease progression independently of the numbers of CD4+ lymphocytes. Proc Natl Acad Sci USA 1994; 91:1104. [ Links ]

    55. Frankel A, Young J. HIV-1: fifteen proteins and an RNA. Annu Rev Biochem 1998; 67:1. [ Links ]

    56. Garnier L, Bowzard J, Wills J. Recent advances and remaining problems in HIV assembly. AIDS 1998; 12:S5. [ Links ]

    57. Jabbar M. The human immunodeficiency virus type 1 Vpu protein: roles in virus release and CD4 downregulation. Curr Top Microb Immunol 1995; 193:107. [ Links ]

    58. Strebel K, Daugherty D, Clouse K et al. The HIV¨A¨(sor) gene product is essential for virus infectivity. Nature 1987; 328:728. [ Links ]

    59. Fisher A, Ensoli B, Ivanoff L et al. The sor gene of HIV-1 is required for efficient virus transmission in vitro. Science 1987; 237:888. [ Links ]

    60. Franke E, Yuan H Luban J et al. Specific incorporation of cyclophilin A into HIV-1 virions. Nature 1994; 372:359. [ Links ]

    61. Thali M, Bukovsky A, Kondo E et al. Functional association of cyclophilin A with HIV-1 virions. Nature 1994; 372:363. [ Links ]

    62. Freskgard P, Bergenhem N, Jonsson B et al. Isomerase and chaperone activity of prolyl isomerase in the folding of carbonic anhydrase. Science 1992; 258:466. [ Links ]

    63. Stamnes M, Rutherford S, Zucker C etal. Cyclophilins: a new family of proteins involved in intracellular folding. Trends Cell Biol 1992; 2:272. [ Links ]

    64. Luban J. Absconding with chaperone: essential cyclophilin-Gag interaction in HIV-1 virions. Cell 1996; 87:1157. [ Links ]

    65. Jones Ka, Kadonaga J,Luciw P et al. Activation of the AIDS retrovirus promoter by the cellular transcription factor SP1. Science 1986; 232:755. [ Links ]

    66. Nabel G, Baltimore D. An inducible transcription factor activates expression of human immnodeficiency virus in T cells. Nature (London) 1987; 326:711. [ Links ]

    67. Harrich D, García J, Wu f et al. Role of SP1-binding domains in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat. J Virol 1989; 63:2585. [ Links ]

    68. Parrot C, Seidner T, Duh E et al. Variable role of the long terminal repeat Sp1-binding sites in human immunodeficiency virus replication in T lympocytes. J Virol 1991; 65:1414. [ Links ]

    69. Ross E, Buckler A, Rabson A et al.Contribution of NF-kB and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1;distinct patterns of viral growth are determined by T-cell types. J Virol 1991; 65:4350. [ Links ]

    70. Nabel G, Rice S, Knipe D et al. AlteARNtive mechanisms for activation of human immunodeficiency virus enhancer in T cells. Science 1988; 239:1299. [ Links ]

    71. Jones K. VIH trans-activation and transcription control mechanisms. New Biol 1989; 1:127. [ Links ]

    72. Haseltine W, Wong-Staal F. Genetic structure nd regulation of VIH. Gene Regulation of Human Retrovirus 1991; 1:1. [ Links ]

    73. Jeang K. En: Myers G, Korber B, Berzofsky J, Smith R, Pavlakis G, eds. Human retroviruses and AIDS. A compilation and analysis of nucleic acid and aminoacid sequences. Los Alamos, N.M., Los Alamos National Laboratory; 1994. [ Links ]

    74. Embretson J, Zupancic M Ribas J et al. Massive covert infection of helper T lymphocytes and macrophages by VIH during the incubation period of AIDS. Nature 1993; 362:359. [ Links ]

    75. Pantaleo G, Graziosi C, Demarest J et al. VIH infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993; 362:355. [ Links ]

    76. Staffa A, Cochrane A. The tat/rev intron of human immunodeficiency virus type 1 is inefficiently soliced because of suboptimal signals in the 3´splice site. J Virol 1994; 68:3071. [ Links ]

    77. Arya S, Gallo R. Three novel genes of human T-cell lymphotropic virus type III; Inmune reactivity of their products with sera from acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 1986; 83:2209. [ Links ]

    78. Benko D, Schwartz S, Pavlakis G. Novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env and rev proteins. J Virol 1990; 64:2505. [ Links ]

    79. Schwartz S, Felber B, Fenyo E et al. Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mARNs. J Virol 1990; 64:5448. [ Links ]

    80. Schwartz S, Felber B, Pavlakis G et al. Expression of human immunodeficiency virus type-1 vif and vpr mARNs is Rev-dependent and regulated by splicing. Virology 1991; 183:677. [ Links ]

    81. Salfed J, Gottlinger H, Sia R et al. A tripartite VIH-1 tat-env-rev fusion protein. EMBO J 1990; 9:965. [ Links ]

    82. Purcell D, Martin M. AlteARNtive splicing of human immunodeficiency virus type 1 mARN modulates viral protein expression, replication and infectivity. J Virol 1993; 67:6365. [ Links ]

    83. Pavlakis G, Schwartz S, D´Agostino D et al. Structure, splicing and regulation of expression of VIH-1; a model for the general organization of lentivirus and other complex retroviruses. En: Kennedy R, Wong-Staat F, Koff W, eds. Annual Review of AIDS Research, p41. New York, Marcel Dekker Inc; 1991. [ Links ]

    84. Gottlinger H, Sodroski J, Haseltine W. Role of capside precursor processing and myristoylation in morphogenesis and infectivity of humanimmunodeficiency virus type 1. Proc Natl Acad Sci USA 1989; 86:5781. [ Links ]

    85. Lewis P, Hensel M, Emerman M. Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J 1992; 11:3053. [ Links ]

    86. Franke E, Luban J. Inhibition of VIH-1 replication by cyclosphorine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin interaction. Virology 1996; 222:279. [ Links ]

    87. Harrison G, Lever A. The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure. J Virol 1992; 66:4144. [ Links ]

    88. Paxton W, Connor R, Landau N. Incorporation of Vpr into human immunodeficiency virus type 1 virions: Requirement for the p6 region of gag and mutational analysis. J Virol 1993; 67:7229. [ Links ]

    89. Jacks T, Power M, Masiarz F et al. Charaacterization of ribosomal frameshifting in VIH-1 Gag-Pol expression. Nature 1988; 331:280. [ Links ]

    90. Parkin N, Chamorro M, Varmus H. Human immunodeficiency virus type 1 gag-pol frameshifting is dependent on mARN secondary structure: Demostration by expression in vivo. J Virol 1992; 66:5147. [ Links ]

    91. Ashorn P, McQuade T, Thaisrivongs S et al. An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection. Proc Natl Acad Sci USA 1990; 87:7472. [ Links ]

    92. Miller M, Jaskolski M, Rao J et al. Crystal structure of a retroviral protease proves relationship to aspartic protease family. Nature 1989; 337:576. [ Links ]

    93. Pruss D, Bushman F, Wolffe A. Human immunodeficiency virus integrase directs integration to sites of severe ADN distortion within the nucleosome core. CROC Natl Acad Sci USA 1994; 91:5913. [ Links ]

    94. Wiskerchen M, Muesing M. Human immunodeficiency virus type 1 integrase: Effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral ADN templates, and sustain viral propagaation in primary cells. J Virol 1995; 69:376. [ Links ]

    95. Moore J, McKeating J, Weiss r et al. Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science 1990; 250:1139. [ Links ]

    96. Hart T, Kirsh R, Ellens H et al. Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glyciprotein gp120. Proc Natl Acad Sci USA 1991; 88:2189. [ Links ]

    97. Sattentau Q, Moore J. Conformational changes in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J Exp Med 1991; 174:407. [ Links ]

    98. Page K, Stearns S, Littman D. Analysis of mutations in the V3 domain of gp160 that affect fusion and infectivity. J Virol 1992; 66:524. [ Links ]

    99. Freed E, Myers D, Risser R. Identification of the principal neutralizing determinant of human immunodeficiency virus type 1 as a fusion domain. J Virol 1991; 65:190. [ Links ]

    100. Hwang S, Boyle T, Lyerly K et al. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 1991; 253:71. [ Links ]

    101. Feng Y, Broder C, Kennedy P et al. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996; 272:872. [ Links ]

    102. Kohlstaedt L, Wang J, Friedman J et al. Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 1992; 256:1783. [ Links ]

    103. Preston B, Poiesz B, Loeb L. Fidelity of HIV-1 reverse transcriptase. Science 1988; 242:1168. [ Links ]

    104. Roberts J, Bebenek K, Kunkel T. The accuracy of reverse transcriptase from HIV-1. Science 1988; 242:1171. [ Links ]

    105. Zapp M, Green M. Sequence-specific RNA binding by the HIV-1 Rev protein. Nature 1989; 342:714. [ Links ]

    106. Kim S, Byrn R, Groopman J et al. Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: Evidence for differential gene expression. J Virol 1989; 63:3708. [ Links ]

    107. Lama J, Mangasarian A, Trono D. Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef and Vpu inhibitable manner. Current Biology 1999; 9:622. [ Links ]

    108. Cullen B. HIV-1 Nef protein: An invitation to a kill. Nature Medicine; 1999; 5,9:585. [ Links ]

    109. García J, Miller A. Downregulation of cell surface CD4 by nef. Res Virol 1992; 143:52. [ Links ]

    110. Aiken C, Konner J, Landau N et al. Nef induces CD4 endocytosis: Requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 1994; 76:853. [ Links ]

    111. Cohen E, Dehni G, Sodroski J et al. Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J Virol 1990; 64:3097. [ Links ]

    112. Rogel M, Wu L, Emerman M. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J Virol 1995; 69:882. [ Links ]

    113. Jowett J, Planelles V, Poon B et al. The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2+ M phase of the cell cycle. J Virol 1995; 69:6304. [ Links ]

    114. Re F, Luban J. HIV-1 Vpr: G2 cell cycle arrest, macrophages and nuclear transport. Prog Cell Cycle Res 1997; 3:21. [ Links ]

    115. Braaten D, Franke E, Luban J. Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B. J Virol 1995; 69:6859. [ Links ]

    116. He J, Choe S, Walker R et al. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J Virol 1995; 69:6705. [ Links ]

    117. Bouhamdan M, Benichou S, Rey F et al. Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme. J Virol 1996; 70:697. [ Links ]

    118. Sato A, Igarashi H, Adachi A et al. Identification and localization of vpr gene product of human immunodeficiency virus type 1. Virus Genes 1990; 4:303. [ Links ]

    119. Schubert U, Bour S, Ferrer- Montiel A et al. The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains. J Virol 1996; 70:809-819. [ Links ]

    120. Willey R, Maldarelli F, Martin M et al. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J Virol 1992; 66(12):7193. [ Links ]

    121. Klimkait T, Strebel K, Hoggan M et al. The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J Virol 1990; 64:621. [ Links ]

    122. Camaur D, Trono D. Characterization of human immunodeficiency virus type 1 Vif particle incorporation. J Virol 1996; 70:6106. [ Links ]

    123. Von Schwedler U, Song J, Aiken C et al. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J Virol 1993; 67:4945. [ Links ]

    124. Houglund S, Ohagen A, Lawrence K et al. Role of vif during packing of the core of HIV-1. Virology 1994; 201(2):349. [ Links ]

    125. Pandori M, Fitch N, Craig H et al. Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein. J Virol 1996; 70:4283. [ Links ]

    126. Schwartz O, Marechal V, Danos O et al. Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription inthe infected cell. J Virol 1995; 69:4053. [ Links ]

    127. Okamoto T, Matsuyama T, Mori S et al. Augmentation of human immunodeficiency virus type 1 gene expression by tumor necrosis factor alpha. AIDS Res Hum Retroviruses 1989; 5:131. [ Links ]

    128. Kobayashi N, Hamamoto Y, Koyanagi Y et al. Effect of interleukin-1 on the augmentation of human immunodeficiency virus gene expression. Bioch Biophys Res Commun 1989; 165:715. [ Links ]

    129. Abbas A, Lichtman A, Pober J. Inmunologia celular y molecular. Interamericana McGrawHill (3 edición). Madrid 1999:505. [ Links ]

    130. Garcia J, Harrich D, Soultanakis E et al. Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation. EMBO J 1989; 8:765. [ Links ]

    131. Sheridan P, Sheline C, Cannon K et al. Activation of the HIV-1 enhancer by the LEF-1 HMG protein on nucleosome-assembled DNA in vitro. Genes Dev 1995; 9:2090. [ Links ]

    132. Kao S, Calman A, Luciw P et al. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature 1987; 330:489. [ Links ]

    133. Sheldon M, Ratnassabapathy R, Hernández N. Characterization of the inducer of short transcripts, a human immunodeficiency virus type 1 transcriptional element that activates the synthesis of short RNAs. Mol Cell Biol 1993; 13:1251. [ Links ]

    134. Myers G, Korber B, Berzofsky J et al. Human retroviruses and AIDS. A compilation and analysis of nucleic acid and amino acid sequences. Human retroviruses and AIDS,1994. [ Links ]

    135. Pathak V, Temin H. Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: Substitutions, frameshifts, and hypermutations. Proc Natl Acad Sc USA 1990; 87:6019. [ Links ]

    136. Vartanian J, Meyerhans A, Asjo B et al. Selection, recombination and G---A hypermutation of human immunodeficiency virus type 1 genomes. J Virol 1991; 65:1779. [ Links ]

    137. Hu W, Temin H. Retroviral recombination and reverse transcription. Science 1990; 250:1227. [ Links ]

    138. Hu W, Temin H. Genetic consequences of packaging two RNA genomes in one retroviral particle: Pseudodiploidy and high rate of genetic recombination. Proc Natl Acad Sci USA 1990; 87:1556. [ Links ]

    139. Wong-Staal F, Shaw , Hahn B et al. Genomic diversity of human T-lymphotropic virus type III(HTLV-III). Science 1985; 229:759. [ Links ]

    140. Starcich B, Hahn B, Shaw G et al. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell 1986; 45:637. [ Links ]

    141. Wain Hobson S, Sonigo P, Danos O et al. Nucleotide sequence of the AIDS virus, LAV. Cell 1985; 40:9. [ Links ]

    142. Barin F, M´Boup S, Denis F et al. Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of West Africa. Lancet 1985; 2:1387. [ Links ]

    143. Kanki P, Barin F, M´Boup S et al. New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III(STLV-III). Science 1986; 232:238. [ Links ]

    144. Kanki P, M´Boup S, Ricard D et al. Human T-lymphotropic virus type 4 and the human immunodeficiency virus in West Africa. Science 1987; 236:827. [ Links ]

    145. Clavel F, Guetard F, Brun F et al. Isolation of a new human retrovirus from West African patients with AIDS. Science 1986; 233:343. [ Links ]

    146. Clavel F, Guayader M, Guetard D et al. Molecular cloning and polymorphism of the human immune deficiency virus type 2. Nature 1986; 324:691. [ Links ]

    147. Clavel F, Mansinho K, Charmaret S et al. Human immunodeficiency virus type 2 infection associated with AIDS in West Africa. N Engl J Med 1987; 316:1180. [ Links ]

    148. Guyader M, Emmerman M, Sonigo P et al. Genome organization and transactivation of the human immunodeficiency virus type 2. Nature 1987; 326:662. [ Links ]

    149. Chakrabarti L, Guyader M, Alizon M et al. Sequence of simian immunodeficiency virus from macaque and its relatioship to other human and simian retroviruses. Nature 1987; 328:543. [ Links ]